...
首页> 外文期刊>Saudi Pharmaceutical Journal >Antidiabetic, antioxidant, molecular docking and HPTLC analysis of miquelianin isolated from Euphorbia schimperi C. Presl
【24h】

Antidiabetic, antioxidant, molecular docking and HPTLC analysis of miquelianin isolated from Euphorbia schimperi C. Presl

机译:偏见磷酸氏菌分离的杀菌剂,抗氧化剂,分子对接与静脉分析分离

获取原文

摘要

The present study demonstrates the miquelianin or quercetin 3- O -glucuronide (compound 1 ) isolated from aerial parts of Euphorbia schimperi exhibited significant results for antioxidant and antidiabetic potential. The compound 1 along with kaempferol 3- O -glucuronide (compound 2 ) and quercetin 3- O -rhamnoside (compound 3 ) isolated from the same source were quantified by validated HPTLC method. Antioxidant activity was determined by chemical means in terms of ABTS radical cation and DPPH radical scavenging activity. Compound 1 showed significant scavenging activity in both ABTS and DPPH assays as compared to standard BHA. In ABTS method ICsub50/sub values of compound 1 and standard BHA is found to be 58.90?±?3.40?μg/mL and 28.70?±?5.20?μg/mL respectively while in DPPH assay ICsub50/sub values of Compound 1 and standard BHA is 47.20?±?4.90?μg/mL and 34.50?±?6.20?μg/mL respectively. Antidiabetic effect was studied through α-amylase and α-glucosidase inhibitory activity. The mechanistic approach through molecular modelling also support the strong binding sites of compound 1 which showed significant α-amylase and α-glucosidase inhibitory activities with ICsub50/sub values 128.34?±?12.30 and 89.20?±?9.20?μg/mL respectively as compared to acarbose 64.20?±?5.60 and 52.40?±?4.60?μg/mL respectively. The results of validated RP-HPTLC analyses revealed the concentration of compound 1 found to be 16.39?μg/mg and for compound 2 and compound 3 as 3.92 and 14.98?μg/mg of dried extract, respectively.
机译:本研究表明,从大戟氏菌的航拍部分分离的瞳孔素或槲皮素3-O-葡萄糖(化合物1)表现出显着的抗氧化剂和抗糖尿病潜力的显着结果。通过验证的HPTLC方法量化了通过验证的HPTLC方法量化了从同一源中分离的kaempferol的3-O-葡糖苷(化合物2)和槲皮素3- o -Rhamnoside(化合物3)的化合物1。通过化学方法在ABTS自由基阳离子和DPPH激进清除活性方面通过化学方法确定抗氧化活性。与标准BHA相比,化合物1在ABTS和DPPH测定中显示出显着的清除活性。在ABTS方法中,化合物1和标准BHA的IC 50 分别在DPPH测定IC 50 化合物1和标准BHA的值分别为47.20≤x≤4.90≤μg/ mL和34.50?±6.20μg/ ml。通过α-淀粉酶和α-葡糖苷酶抑制活性研究了抗糖尿病效应。通过分子建模的机械方法还支持化合物1的强粘结位点,其显示出显着的α-淀粉酶和α-葡萄糖苷酶抑制活性,IC 50 值128.34?±12.30和89.20?±9.20?分别与炭疽病64.20α±5.60和52.40?±4.60×μg/ mL相比,分别与μg/ mL相比。验证的RP-HPTLC分析结果显示出发现的化合物1的浓度为16.39Ω·μg/ mg,化合物2和化合物3分别为3.92和14.98Ωμg/ mg干燥提取物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号